Advertisement

Clinical Orthopaedics and Related Research

, Volume 467, Issue 2, pp 510–518 | Cite as

Osteosarcoma of the Pelvis: Outcome Analysis of Surgical Treatment

  • Bruno Fuchs
  • Nathan Hoekzema
  • Dirk R. Larson
  • Carrie Y. Inwards
  • Franklin H. Sim
Original Article

Abstract

Risk factors to explain the poor survival of patients with osteosarcoma of the pelvis are poorly understood. Therefore, we attempted to identify factors affecting survival and development of local recurrence and metastasis. We retrospectively reviewed 43 patients who had high-grade pelvic tumors and were treated surgically. Twenty lesions were chondroblastic, 10 fibroblastic, 11 osteoblastic, and one each was giant cell-rich and small cell osteosarcomas. At a median of 3.5 years (range, 0.3–21 years) postoperatively, 13 patients were alive with no evidence of disease. The overall and disease-free 5-year survival rates were 38% and 29%, respectively, at 5 years. Anatomic location, tumor size, and margin predicted survival. Fifteen patients (35%) had local recurrence. The 5-year cumulative incidence of recurrence with death as a competing risk factor was 34%. Location in the ilium and size of the tumor predicted local recurrence. Twenty-one (49%) of 43 patients had metastases develop. The cumulative incidence of metastasis with death as a competing risk factor was 48% at 5 years. Six patients who presented with metastasis had a worse survival than patients who had no evidence of metastasis at presentation (2-year survival, 33% versus 76%). If distant metastasis is diagnosed subsequent to primary treatment, aggressive therapy may be justified.

Level of Evidence: Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.

Keywords

Local Recurrence Osteosarcoma Fibrous Dysplasia Sacroiliac Joint Adequate Margin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jurgens H, Winkler K. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776–790. PubMedCrossRefGoogle Scholar
  2. 2.
    Bielack SS, Wulff B, Delling G, Gobel U, Kotz R, Ritter J, Winkler K. Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS). Med Pediatr Oncol. 1995;24:6–12. PubMedCrossRefGoogle Scholar
  3. 3.
    Campanacci M, Ruggieri P. Osteosarcoma. Bull Hosp Jt Dis Orthop Inst. 1991;51:1–11. PubMedGoogle Scholar
  4. 4.
    Donati D, Giacomini S, Gozzi E, Ferrari S, Sangiorgi L, Tienghi A, DeGroot H, Bertoni F, Bacchini P, Bacci G, Mercuri M. Osteosarcoma of the pelvis. Eur J Surg Oncol. 2004;30:332–340. PubMedCrossRefGoogle Scholar
  5. 5.
    Enneking WF, Dunham WK. Resection and reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg Am. 1978;60:731–746. PubMedGoogle Scholar
  6. 6.
    Fahey M, Spanier SS, Vander Griend RA. Osteosarcoma of the pelvis: a clinical and histopathological study of twenty-five patients. J Bone Joint Surg Am. 1992;74:321–330. PubMedGoogle Scholar
  7. 7.
    Frassica FJ, Sim FH, Frassica DA, Wold LE. Survival and management considerations in postirradiation osteosarcoma and Paget’s osteosarcoma. Clin Orthop Relat Res. 1991;270:120–127. PubMedGoogle Scholar
  8. 8.
    Fuchs B, Pritchard DJ. Etiology of osteosarcoma. Clin Orthop Relat Res. 2002;397:40–52. PubMedCrossRefGoogle Scholar
  9. 9.
    Fuchs B, Yaszemski MJ, Sim FH. Combined posterior pelvis and lumbar spine resection for sarcoma. Clin Orthop Relat Res. 2002;397:12–18. PubMedCrossRefGoogle Scholar
  10. 10.
    Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706. PubMedCrossRefGoogle Scholar
  11. 11.
    Grimer RJ, Carter SR, Tillman RM, Spooner D, Mangham DC, Kabukcuoglu Y. Osteosarcoma of the pelvis. J Bone Joint Surg Br. 1999;81:796–802. PubMedCrossRefGoogle Scholar
  12. 12.
    Ham SJ, Kroon HM, Koops HS, Hoekstra HJ. Osteosarcoma of the pelvis: oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol. 2000;26:53–60. PubMedCrossRefGoogle Scholar
  13. 13.
    Hayden JB, Hoang BH. Osteosarcoma: basic science and clinical implications. Orthop Clin North Am. 2006;37:1–7. PubMedCrossRefGoogle Scholar
  14. 14.
    Hugate RR, Wilkins RM, Kelly CM, Madsen W, Hinshaw I, Camozzi AB. Intraarterial chemotherapy for extremity osteosarcoma and MFH in adults. Clin Orthop Relat Res. 2008;466:1292–1301. PubMedCrossRefGoogle Scholar
  15. 15.
    Huth JF, Eckardt JJ, Pignatti G, Eilber FR. Resection of malignant bone tumors of the pelvic girdle without extremity amputation. Arch Surg. 1988;123:1121–1124. PubMedGoogle Scholar
  16. 16.
    Inoue YZ, Frassica FJ, Sim FH, Unni KK, Petersen IA, McLeod RA. Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue. J Surg Oncol. 2000;75:42–50. PubMedCrossRefGoogle Scholar
  17. 17.
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481. CrossRefGoogle Scholar
  18. 18.
    Kawai A, Huvos AG, Meyers PA, Healey JH. Osteosarcoma of the pelvis: oncologic results of 40 patients. Clin Orthop Relat Res. 1998;348:196–207. PubMedCrossRefGoogle Scholar
  19. 19.
    Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51:524–532. PubMedCrossRefGoogle Scholar
  20. 20.
    Matsuo T, Sugita T, Sato K, Hotta T, Tsuchiya H, Shimose S, Kubo T, Ochi M. Clinical outcomes of 54 pelvic osteosarcomas registered by Japanese Musculoskeletal Oncology Group. Oncology. 2005;68:375–381. PubMedCrossRefGoogle Scholar
  21. 21.
    Meyers PA, Gorlick R. Osteosarcoma. Pediatr Clin North Am. 1997;44:973–989. PubMedCrossRefGoogle Scholar
  22. 22.
    O’Connor MI, Sim FH. Salvage of the limb in the treatment of malignant pelvic tumors. J Bone Joint Surg Am. 1989;71:481–494. PubMedGoogle Scholar
  23. 23.
    Ozaki T, Flege S, Kevric M, Lindner N, Maas R, Delling G, Schwarz R, von Hochstetter AR, Salzer-Kuntschik M, Berdel WE, Jurgens H, Exner GU, Reichardt P, Mayer-Steinacker R, Ewerbeck V, Kotz R, Winkelmann W, Bielack SS. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol. 2003;21:334–341. PubMedCrossRefGoogle Scholar
  24. 24.
    Pollock BH, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr. 1991;119:725–732. PubMedCrossRefGoogle Scholar
  25. 25.
    Saab R, Rao BN, Rodriguez-Galindo C, Billups CA, Fortenberry TN, Daw NC. Osteosarcoma of the pelvis in children and young adults: the St Jude Children’s Research Hospital experience. Cancer. 2005;103:1468–1474. PubMedCrossRefGoogle Scholar
  26. 26.
    Shin KH, Rougraff BT, Simon MA. Oncologic outcomes of primary bone sarcomas of the pelvis. Clin Orthop Relat Res. 1994;304:207–217. PubMedGoogle Scholar
  27. 27.
    Taylor WF, Ivins JC, Dahlin DC, Edmonson JH, Pritchard DJ. Trends and variability in survival from osteosarcoma. Mayo Clin Proc. 1978;53:695–700. PubMedGoogle Scholar
  28. 28.
    Wurtz LD, Peabody TD, Simon MA. Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis. J Bone Joint Surg Am. 1999;81:317–325. PubMedCrossRefGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons 2008

Authors and Affiliations

  • Bruno Fuchs
    • 1
  • Nathan Hoekzema
    • 2
  • Dirk R. Larson
    • 3
  • Carrie Y. Inwards
    • 4
  • Franklin H. Sim
    • 2
  1. 1.Division of Orthopedic Oncology, Department of OrthopedicsBalgrist University Hospital, University of ZurichZurichSwitzerland
  2. 2.Division of Orthopedic OncologyMayo ClinicRochester USA
  3. 3.Department of BiostatisticsMayo ClinicRochesterUSA
  4. 4.Department of Surgical PathologyMayo ClinicRochester USA

Personalised recommendations